Navigation Links
What Is Keratosis Pilaris (KP)?
Date:7/27/2009

MINNEAPOLIS, July 27 /PRNewswire/ -- KP is a genetic skin condition that affects 40 percent of the world's population, often resulting in patches of dry skin, and little red bumps, on the arms and legs. KP is most prevalent in the teenage years but may continue throughout adulthood. There is no cure for Keratosis Pilaris.(1, 2)

Dr. Alan B. Fleischer, professor and chair of the department of dermatology at Wake Forest University School of Medicine, recommends keeping skin moisturized to help manage the dry skin associated with KP by using products containing lactic acid, such as AmLactin(R) or AmLactin XL(R).

Littleredbumps.com, a website devoted to the management of the dry skin associated with Keratosis Pilaris, is brought to you by the AmLactin(R) family of moisturizers. AmLactin(R) is the #1 recommended moisturizer by dermatologists and is available without a prescription.(3) For more information and to download valuable coupons visit www.littleredbumps.com.

About Keratosis Pilaris and littleredbumps.com

There is no cure for Keratosis Pilaris (KP) and the cause remains unknown, however it tends to run in families.(2) People with KP may experience flesh-colored or red bumps around hair follicles on the upper arms, thighs, buttocks, and cheeks, extremely dry skin and, in some cases, itching.(1,2) It is important to be aware that other medical conditions can mimic KP, so people with these symptoms should visit a doctor to confirm a diagnosis.

Littleredbumps.com and The AmLactin(R) family of moisturizers are not intended to diagnose, treat, cure or prevent any medical condition. Some skin conditions may be worsened by moisturizers, so people should always follow their doctor's skin care recommendations.

AmLactin(R)

The AmLactin(R) family of moisturizers are the number one dermatologist and podiatrist recommended brand of moisturizers (1,3,4) and are readily available without a prescription at fine retailers nationwide and online. For more information, visit www.amlactin.com.

Upsher-Smith

Upsher-Smith Laboratories, Inc. is a rapidly-growing pharmaceutical company that manufactures and markets both prescription and consumer products. Upsher-Smith prides itself on providing safe, effective and economical therapies to the ever-challenged healthcare environment. For more information, visit www.upsher-smith.com.

(1) www.aad.org/public/publications/pamphlets/skin_dry.html

(2) Nili, A. Keratosis pilaris. September 2008. http://www.emedicine.medscape.com

(3) Rough, Dry skin: most recommended moisturizing product. Omnibus Study. Dermatology Times. 2008.

(4) Kloos Donoghue S. Podiatry management annual practice survey. Podiatry Management. February 2009.


'/>"/>
SOURCE Upsher-Smith Laboratories, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/27/2016)... ... June 27, 2016 , ... ... announced its strategic partnership with Connance, a healthcare industry leader providing predictive ... proven, proprietary technology combine to provide health systems, hospitals and ambulatory surgical ...
(Date:6/26/2016)... ... June 26, 2016 , ... Pixel Film Studios Released ... , "Film editors can give their videos a whole new perspective by using the ... CEO of Pixel Film Studios. , ProSlice Levels contains over 30 Different presets ...
(Date:6/25/2016)... ... June 25, 2016 , ... Austin residents seeking Mohs ... College of Mohs Surgery and to Dr. Russell Peckham for medical and surgical dermatology. ... treatment for skin cancer. The selective fellowship in Mohs Micrographic Surgery completed by Dr. ...
(Date:6/25/2016)... City, Oklahoma (PRWEB) , ... June 25, 2016 ... ... helping both athletes and non-athletes recover from injury. Recently, he has implemented orthobiologic ... the Oklahoma City area —Johnson is one of the first doctors to perform ...
(Date:6/24/2016)... (PRWEB) , ... June 24, 2016 , ... June 19, ... the dangers associated with chronic pain and the benefits of holistic treatments, Serenity ... who are suffering with Sickle Cell Disease. , Sickle Cell Disease (SCD) is a ...
Breaking Medicine News(10 mins):
(Date:6/24/2016)... 24, 2016  Global Blood Therapeutics, Inc. (GBT) (NASDAQ: ... novel therapeutics for the treatment of grievous blood-based ... closing of its previously announced underwritten public offering ... public offering price of $18.75 per share. All ... by GBT. GBT estimates net proceeds from the ...
(Date:6/24/2016)... BEIJING , June 24, 2016 Dehaier ... or the "Company"), which develops, markets and sells medical ... China , signed a strategic cooperation agreement with ... as "Hongyuan Supply Chain") on June 20, 2016, to ... Under the strategic cooperation agreement, Dehaier will leverage Hongyuan ...
(Date:6/24/2016)... NAMUR , Belgium , ...  (NYSE MKT: VNRX), today announced the appointment of ... Board of Directors as a Non-Executive Director, effective ... the Company,s Audit, Compensation and Nominations and Governance ... Board, Dr. Futcher will provide independent expertise and ...
Breaking Medicine Technology: